| Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials MJ Sorich, MD Wiese, A Rowland, G Kichenadasse, RA McKinnon, ... Annals of Oncology 26 (1), 13-21, 2015 | 609 | 2015 |
| Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism L Wang, CT Christophersen, MJ Sorich, JP Gerber, MT Angley, ... Applied and environmental microbiology 77 (18), 6718-6721, 2011 | 463 | 2011 |
| Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder L Wang, CT Christophersen, MJ Sorich, JP Gerber, MT Angley, ... Digestive diseases and sciences 57, 2096-2102, 2012 | 426 | 2012 |
| Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder L Wang, CT Christophersen, MJ Sorich, JP Gerber, MT Angley, ... Molecular autism 4, 1-4, 2013 | 425 | 2013 |
| Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer A Rowland, MM Dias, MD Wiese, G Kichenadasse, RA McKinnon, ... British journal of cancer 112 (12), 1888-1894, 2015 | 380 | 2015 |
| Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non–small cell lung cancer G Kichenadasse, JO Miners, AA Mangoni, A Rowland, AM Hopkins, ... JAMA oncology 6 (4), 512-518, 2020 | 252 | 2020 |
| Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches JO Miners, PA Smith, MJ Sorich, RA McKinnon, PI Mackenzie Annu. Rev. Pharmacol. Toxicol. 44, 1-25, 2004 | 250 | 2004 |
| Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers AM Hopkins, A Rowland, G Kichenadasse, MD Wiese, H Gurney, ... British journal of cancer 117 (7), 913-920, 2017 | 175 | 2017 |
| CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated … MJ Sorich, A Rowland, RA McKinnon, MD Wiese Circulation: cardiovascular genetics 7 (6), 895-902, 2014 | 142 | 2014 |
| Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift AM Hopkins, JM Logan, G Kichenadasse, MJ Sorich JNCI Cancer Spectrum 7 (2), pkad010, 2023 | 137 | 2023 |
| Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms MJ Sorich, JO Miners, RA McKinnon, DA Winkler, FR Burden, PA Smith Journal of chemical information and computer sciences 43 (6), 2019-2024, 2003 | 133 | 2003 |
| Prasugrel vs. clopidogrel for cytochrome P450 2C19‐genotyped subgroups: integration of the TRITON‐TIMI 38 trial data MJ Sorich, A Vitry, MB Ward, JD Horowitz, RA McKinnon Journal of Thrombosis and Haemostasis 8 (8), 1678-1684, 2010 | 129 | 2010 |
| The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic … T Prasanna, CS Karapetis, D Roder, J Tie, R Padbury, T Price, R Wong, ... Acta Oncologica 57 (11), 1438-1444, 2018 | 102 | 2018 |
| In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile MJ Sorich, N Pottier, D Pei, W Yang, L Kager, G Stocco, C Cheng, ... PLoS Medicine 5 (4), e83, 2008 | 97 | 2008 |
| Partial charge calculation method affects CoMFA QSAR prediction accuracy RR Mittal, L Harris, RA McKinnon, MJ Sorich Journal of chemical information and modeling 49 (3), 704-709, 2009 | 88 | 2009 |
| Evaluation of the lung immune prognostic index for prediction of survival and response in patients treated with atezolizumab for NSCLC: pooled analysis of clinical trials MJ Sorich, A Rowland, CS Karapetis, AM Hopkins Journal of Thoracic Oncology 14 (8), 1440-1446, 2019 | 86 | 2019 |
| Pharmacophore and quantitative structure− activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 … PA Smith, MJ Sorich, RA McKinnon, JO Miners Journal of medicinal chemistry 46 (9), 1617-1626, 2003 | 85 | 2003 |
| Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates MJ Sorich, PA Smith, RA McKinnon, JO Miners Pharmacogenetics and Genomics 12 (8), 635-645, 2002 | 84 | 2002 |
| A critical analysis of barriers to the clinical implementation of pharmacogenomics RA McKinnon, MB Ward, MJ Sorich Therapeutics and clinical risk management 3 (5), 751-759, 2007 | 82 | 2007 |
| Concomitant proton pump inhibitor use and survival in urothelial carcinoma treated with atezolizumab AM Hopkins, G Kichenadasse, CS Karapetis, A Rowland, MJ Sorich Clinical Cancer Research 26 (20), 5487-5493, 2020 | 78 | 2020 |
Andrew RowlandFlinders University在 flinders.edu.au 的电子邮件经过验证
